Google News – Oncology External News
Life Sciences & Pharma Articles
Google News – Oncology External News
Roche pens $490m Astex breast cancer license deal - Pharmaceutical Technology
Google News – Oncology External News
GSK’s licensor Hansoh Pharma announces positive results from a second phase III trial for Ris-Rez in China - GSK
Google News – Oncology External News
AstraZeneca pays up to $1.5bn to license Dizal Pharma’s lung cancer drug - Pharmaceutical Technology
Google News – EMA (biotech/pharma) External News
EMA approval gives Wegovy greater flexibility in supplying patients - medwatch.com
Google News – EMA (biotech/pharma) External News
Anavex Life Sciences Stock Sparks Retail Banter On Hopes Of EMA Conditional Nod For Alzheimer's Drug, Big Pharma Tie-Up - Stocktwits
Google News – FDA (biotech/pharma) External News
Tavneos trial flagged for 'serious breaches' of protocol as EU regulators dissect market withdrawal decision - Fierce Pharma
Google News – FDA (biotech/pharma) External News
AbelZeta Regains Global Rights of C-CAR039 (Prizlon-cel) and Receives FDA Clearance of IND Application in Large B-cell Lymphoma - Bennington Banner
Google News – FDA (biotech/pharma) External News
Aurobindo Pharma Gains 2% After US Plant Clears FDA Review - Equitypandit
Google News – FDA (biotech/pharma) External News
Aurobindo Pharma’s Raleigh plant gets 'Voluntary Action Indicated' classification from US FDA - The Economic Times
Google News – FDA (biotech/pharma) External News
FDA selects Lilly, Regeneron, Fujifilm, 4 others for PreCheck Pilot Program - Fierce Pharma
Google News – FDA (biotech/pharma) External News
Qihan Biotech's QT-019B Receives FDA RMAT and BTD - Business Wire
Google News – FDA (biotech/pharma) External News
Pharma Mar Says Jazz Pharmaceuticals To Seek FDA Withdrawal Of Zepzelca Second-line Use - TradingView
Google News – FDA (biotech/pharma) External News
Production problems hamper Lantheus bid for FDA approval of radiopharma dx kit - Fierce Biotech
Google News – Digital Health External News